missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ ABT 199

Catalog No. 696050
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
696050 50 mg
696010 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. 696050 Supplier R&D Systems™ Supplier No. 6960/50

Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.

A Tocris product, part of R&D Systems. Selective, high affinity Bcl-2 inhibitor; orally bioavailable

ABT 199 is a selective, high affinity Bcl-2 inhibitor (Ki < 0.010 nM). Exhibits >4800-fold selectivity for Bcl-2 over Bcl-xL and Bcl-w, and displays no measurable activity at Mcl-1 (Ki > 444 nM). Potently induces apoptosis in FL5.12-BCL-2 cells (EC50 = 261 nM) and reduces tumor burden in chronic lymphocytic leukemia (CLL) primary samples (EC50 = 3 nM). Shows reduced toxicity to platelets compared to similar compounds. Enhances efficacy of clinically relevant chemotherapy and immunotherapy drugs. Orally bioavailable. Exhibits binding to SARS-CoV-2 3C-like protease (3CLpro) active site in a virtual screen. ABT 199 reverses oxidative phosphorylation in acute myeloid leukemia cells (AML), in vitro and in vivo.

Specifications

Chemical Name or Material 4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2 H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1 H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
CAS 1257044-40-8
Synonym GDC-0199
Quantity 50 mg
Product Line Tocris
Target Bcl-2 Family Inhibitors
Molecular Formula C45H50ClN7O7S
Formula Weight 868.45
Product Type Inhibitor
Purity 98%